Literature DB >> 15358319

Analysis of non-covalent aggregation of synthetic hPTH (1-34) by size-exclusion chromatography and the importance of suppression of non-specific interactions for a precise quantitation.

Marika Kamberi1, Paul Chung, Richard DeVas, Lily Li, Zengji Li, Xiaoyan Sharon Ma, Steven Fields, Christopher M Riley.   

Abstract

There are few methods available for the rapid and precise quantitation of non-covalent aggregation. Size-exclusion chromatography (SEC), a traditional approach, used to measure the non-covalent aggregation can easily disrupt the weak forces holding an aggregate together. Under the conditions described in this paper the disaggregation of non-covalent aggregate of the synthetic human parathyroid hormone hPTH (1-34) due to hydrophobic/electrostatic interactions with the size-exclusion chromatography column packing was completely suppressed. This report details the effectiveness of adding salts and organic solvents in the mobile phase to overcome non-specific interactions that disrupt the aggregate during the SEC process and may aid in the understanding precise quantitation of non-covalent aggregation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358319     DOI: 10.1016/j.jchromb.2004.07.026

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  7 in total

1.  Scientific considerations for generic synthetic salmon calcitonin nasal spray products.

Authors:  Sau L Lee; Lawrence X Yu; Bing Cai; Gibbes R Johnsons; Amy S Rosenberg; Barry W Cherney; Wei Guo; Andre S Raw
Journal:  AAPS J       Date:  2010-10-30       Impact factor: 4.009

Review 2.  Role of analytical ultracentrifugation in assessing the aggregation of protein biopharmaceuticals.

Authors:  Steven A Berkowitz
Journal:  AAPS J       Date:  2006-09-22       Impact factor: 4.009

3.  Long-term stability and in vitro release of hPTH(1-34) from a multi-reservoir array.

Authors:  Elizabeth R Proos; James H Prescott; Mark A Staples
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

4.  Scientific considerations in the review and approval of generic enoxaparin in the United States.

Authors:  Sau Lee; Andre Raw; Lawrence Yu; Robert Lionberger; Naiqi Ya; Daniela Verthelyi; Amy Rosenberg; Steve Kozlowski; Keith Webber; Janet Woodcock
Journal:  Nat Biotechnol       Date:  2013-03       Impact factor: 54.908

Review 5.  Biophysical characterization of recombinant proteins: a key to higher structural genomics success.

Authors:  Masoud Vedadi; Cheryl H Arrowsmith; Abdellah Allali-Hassani; Guillermo Senisterra; Gregory A Wasney
Journal:  J Struct Biol       Date:  2010-05-11       Impact factor: 2.867

6.  Size-Exclusion Chromatography for the Analysis of Protein Biotherapeutics and their Aggregates.

Authors:  Paula Hong; Stephan Koza; Edouard S P Bouvier
Journal:  J Liq Chromatogr Relat Technol       Date:  2012-11-30       Impact factor: 1.467

7.  Direct coupling of size exclusion chromatography and mass spectrometry for the characterization of complex monoclonal antibody products.

Authors:  Amarande Murisier; Marie Andrie; Szabolcs Fekete; Matthew Lauber; Valentina D'Atri; Katharina Iwan; Davy Guillarme
Journal:  J Sep Sci       Date:  2022-03-28       Impact factor: 3.614

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.